Results for “ ”

Entry Author Date Location
Tocagen Plans IPO to Finance Trials of Gene Therapy in Brain Cancer 03/10/17 San Diego
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
BioAffinity Secures $150K Investment from San Antonio-Run Biz Group 03/09/17 Texas
Biotech With Drug Developed by San Antonio Researcher Explores Sale 03/09/17 Texas
Larry Smarr Drives Innovation as Experimental Patient of the Future 03/09/17 San Diego
Houston’s Biotech Innovation Community Reacts to Robbins Exit at TMC 03/08/17 Texas
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
DePinho Announces His Departure from Houston’s MD Anderson 03/08/17 Texas
TMC CEO Robbins To Leave, Take Top University of Arizona Post 03/08/17 Texas
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
CureMatch Uses Analytics to Rank Best Options for Cancer Treatment 03/07/17 San Diego
Bluegrass Vascular Gets Funding, Signs Distribution Deal With Merit 03/06/17 Texas
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
Ingeneron Gets $20M From Sanford Health For Stem Cell Treatment 03/06/17 Texas
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
Evestra Signs Deal with Glemark for Generic Version of NuvaRing 03/01/17 Texas
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells 03/01/17 Texas
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
Medisafe Takes In $14.5M to Help Patients Manage Medications 03/01/17 Boston
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
FDA Approves Houston Biotech Lexicon’s Carcinoid Syndrome Diarrhea Drug 02/28/17 Texas
With Eye On FDA, Kite Says CAR-T For Lymphoma Holds Up After 6 Months 02/28/17 National
Blood Pressure Drug Trial Results Lift La Jolla Pharma Shares 02/27/17 San Diego
Page 2 of 318 « previous page · next page »